In a previous report by Sato et al., MEK inhibitors reversed the resistance of glioblastoma cells to TMZ, and MEK inhibitors combined with TMZ effectively controlled the occurrence and development of glioblastoma cells. Here, MAP2K7 is linked to glioblastoma.